Jacobio Pharma Partners with Oceanpine Capital for Oncology Pipeline Advancement Jacobio Pharma has joined forces with Oceanpine Capital to enhance its oncology pipeline, focusing on innovative cancer therapies and operational efficiency.

Jacobio Pharma Partners with Oceanpine Capital for Oncology Pipeline Advancement #China #Beijing #oncology #Jacobio_Pharma #Oceanpine_Capital

LakeShore Biopharma Receives Acquisition Proposal from Oceanpine Capital LakeShore Biopharma has received a preliminary non-binding proposal to be acquired for $0.86 per share, marking a 10.3% premium over recent prices.

LakeShore Biopharma Receives Acquisition Proposal from Oceanpine Capital #China #Beijing #LakeShore_Biopharma #Oceanpine_Capital #firm_acquisition